Late Breaking Abstract - Parenchymal lung abnormalities , clinical severity and outcomes in patients with COVID 19 pneumonia: a prospective longitudinal observational study
A. Prakash (Gurgaon (Haryana), India), B. Datta (Gurgaon (Haryana), India), M. Singh (Gurgaon (Haryana), India), K. Yaddanapudi (tucson,Arizona, United States), K. Ahlawat (Gurgaon (Haryana), India), J. Tripathy (nagpur, India), P. Goyal (Gurgaon (Haryana), India), S. Mittal (Gurgaon (Haryana), India), N. Gupta (Gurgaon (Haryana), India), S. Parvathi (Gurgaon (Haryana), India), A. Jaiswal (Gurgaon (Haryana), India), P. Singh (Gurgaon (Haryana), India), S. Pipavat (seattle,washington, United States), G. Raghu (seattle, washington, United States)
Source: International Congress 2022 – Respiratory inflammation and the pulmonary consequences of COVID-19
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Prakash (Gurgaon (Haryana), India), B. Datta (Gurgaon (Haryana), India), M. Singh (Gurgaon (Haryana), India), K. Yaddanapudi (tucson,Arizona, United States), K. Ahlawat (Gurgaon (Haryana), India), J. Tripathy (nagpur, India), P. Goyal (Gurgaon (Haryana), India), S. Mittal (Gurgaon (Haryana), India), N. Gupta (Gurgaon (Haryana), India), S. Parvathi (Gurgaon (Haryana), India), A. Jaiswal (Gurgaon (Haryana), India), P. Singh (Gurgaon (Haryana), India), S. Pipavat (seattle,washington, United States), G. Raghu (seattle, washington, United States). Late Breaking Abstract - Parenchymal lung abnormalities , clinical severity and outcomes in patients with COVID 19 pneumonia: a prospective longitudinal observational study. 4272
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|